Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002058129-25-000009
Filing Date
2025-11-25
Accepted
2025-11-25 16:17:30
Documents
2
Period of Report
2025-11-25

Document Format Files

Seq Description Document Type Size
1 form4-11252025_091124.html 4  
1 form4-11252025_091124.xml 4 3703
2 ex24-11252025_091124.htm EX-24 4037
  Complete submission text file 0002058129-25-000009.txt   9114
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064
Business Address
Shroff Eric (Reporting) CIK: 0002058129 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-02189 | Film No.: 251521488